Sera Price To Sales Ratio from 2010 to 2024

SERA Stock  USD 6.54  0.43  7.04%   
Sera Prognostics' Price To Sales Ratio is decreasing over the years with slightly volatile fluctuation. Price To Sales Ratio is expected to dwindle to 579.25. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Sera Prognostics' market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
609.7382319
Current Value
579.25
Quarterly Volatility
4.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sera Prognostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sera Prognostics' main balance sheet or income statement drivers, such as Net Interest Income of 1.7 M, Interest Income of 1.7 M or Depreciation And Amortization of 1.1 M, as well as many indicators such as Price To Sales Ratio of 579, Dividend Yield of 0.0 or PTB Ratio of 2.79. Sera financial statements analysis is a perfect complement when working with Sera Prognostics Valuation or Volatility modules.
  
Check out the analysis of Sera Prognostics Correlation against competitors.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

Latest Sera Prognostics' Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Sera Prognostics over the last few years. Price to Sales Ratio is figured by comparing Sera Prognostics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Sera Prognostics sales, a figure that is much harder to manipulate than other Sera Prognostics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Sera Prognostics' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sera Prognostics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 2,195 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Sera Price To Sales Ratio Regression Statistics

Arithmetic Mean8,000
Geometric Mean4,898
Coefficient Of Variation56.95
Mean Deviation3,745
Median10,148
Standard Deviation4,556
Sample Variance20.8M
Range14.5K
R-Value(0.67)
Mean Square Error12.3M
R-Squared0.45
Significance0.01
Slope(682.51)
Total Sum of Squares290.6M

Sera Price To Sales Ratio History

2024 579.25
2023 609.74
2022 145.48
2021 2578.27
202014.6 K

About Sera Prognostics Financial Statements

Sera Prognostics stakeholders use historical fundamental indicators, such as Sera Prognostics' Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Sera Prognostics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sera Prognostics' assets and liabilities are reflected in the revenues and expenses on Sera Prognostics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sera Prognostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 609.74  579.25 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sera Prognostics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sera Prognostics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sera Prognostics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sera Prognostics Stock:
Check out the analysis of Sera Prognostics Correlation against competitors.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.
You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sera Prognostics. If investors know Sera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sera Prognostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.99)
Revenue Per Share
0.003
Quarterly Revenue Growth
(0.31)
Return On Assets
(0.27)
Return On Equity
(0.50)
The market value of Sera Prognostics is measured differently than its book value, which is the value of Sera that is recorded on the company's balance sheet. Investors also form their own opinion of Sera Prognostics' value that differs from its market value or its book value, called intrinsic value, which is Sera Prognostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sera Prognostics' market value can be influenced by many factors that don't directly affect Sera Prognostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sera Prognostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sera Prognostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sera Prognostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.